With there being a vast variation in gynecological tumor types, physicians will need to review and ensure that the responsible MDs provide the patient with NCCN, SG, and WHO guideline appropriate care. Pathology and imagine reviewed for each tumor to determine typical and atypical features that might influence treatment in gynecological cancers.

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1)Discuss FIGO staging guidelines for gynecologic cancers.  (2)Identify standards of care for patients with gynecologic cancers.  (3)Describe new therapeutic approaches for patients with gynecologic cancer.

FACULTY DISCLOSURE: C. Allen Stringer, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

PLANNERS DISCLOSURES:  C. Allen Stringer, MD; Colin Koon, MD; Carolyn Matthews, MD; and Monique Spillman, MD do not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

For information please contact Alison Porter at [email protected]